Back
Also listed as
ARGNF
OTC
Day Range
$678.67
$692.59
52-Week Range
$510.06
$934.62
Volume
388,008
50D / 200D Avg
$791.83
/
$749.96
Prev Close
$663.93
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 32.6 | 0.4 |
| P/B | 5.8 | 2.9 |
| ROE % | 20.2 | 3.7 |
| Net Margin % | 31.1 | 3.9 |
| Rev Growth 5Y % | 70.1 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$1,026.71
+50.6%
Low: $858.00
High: $1,317.00
Forward P/E
25.8
Forward EPS
$26.47
EPS Growth (est.)
+0.0%
Est. Revenue
6 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$59.47
$51.80 – $67.36
|
11 B | 5 |
| FY2029 |
$51.95
$45.25 – $58.84
|
9.8 B | 11 |
| FY2028 |
$45.30
$39.46 – $51.32
|
8.5 B | 9 |
Key Takeaways
Revenue grew 70.11% annually over 5 years — strong growth
Earnings grew 55.58% over the past year
ROE of 20.22% indicates high profitability
Net margin of 31.12% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 844.30M in free cash flow
Growth
Revenue Growth (5Y)
70.11%
Revenue (1Y)90.12%
Earnings (1Y)55.58%
FCF Growth (3Y)N/A
Quality
Return on Equity
20.22%
ROIC9.85%
Net Margin31.12%
Op. Margin23.35%
Safety
Debt / Equity
0.01
Current Ratio5.23
Interest Coverage237.50
Valuation
P/E Ratio
32.56
P/B Ratio5.76
EV/EBITDA39.89
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 90.12% | Revenue Growth (3Y) | 84.27% |
| Earnings Growth (1Y) | 55.58% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 70.11% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.16B | Net Income (TTM) | 1.30B |
| ROE | 20.22% | ROA | 14.93% |
| Gross Margin | 89.14% | Operating Margin | 23.35% |
| Net Margin | 31.12% | Free Cash Flow (TTM) | 844.30M |
| ROIC | 9.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 5.23 |
| Interest Coverage | 237.50 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 32.56 | P/B Ratio | 5.76 |
| P/S Ratio | 10.13 | PEG Ratio | 0.77 |
| EV/EBITDA | 39.89 | Dividend Yield | 0.00% |
| Market Cap | 42.20B | Enterprise Value | 38.79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.16B | 2.19B | 1.23B | 410.75M | 497.28M |
| Net Income | 1.30B | 833.04M | -295.05M | -709.59M | -407.63M |
| EPS (Diluted) | 19.63 | 12.78 | -5.16 | -13.05 | -7.99 |
| Gross Profit | 3.71B | 1.96B | 1.11B | 381.32M | 497.28M |
| Operating Income | 972.46M | -21.65M | -425.05M | -720.34M | -348.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.68B | 6.20B | 4.54B | 3.13B | 2.85B |
| Total Liabilities | 1.36B | 704.24M | 444.95M | 320.56M | 316.05M |
| Shareholders' Equity | 7.32B | 5.50B | 4.10B | 2.81B | 2.53B |
| Total Debt | 83.49M | 39.05M | 20.00M | 12.43M | 11.47M |
| Cash & Equivalents | 3.49B | 1.50B | 2.05B | 800.74M | 1.33B |
| Current Assets | 6.90B | 4.88B | 4.12B | 2.77B | 2.54B |
| Current Liabilities | 1.32B | 669.92M | 422.99M | 302.28M | 301.24M |
Strategy Scores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recent Activity
Entered
Growth Investing (Philip Fisher)
Mar 24, 2026
Entered
Full Throttle
Mar 24, 2026
Entered
Lower Risk
Mar 24, 2026